1. A systematic review of whether COVID‐19 randomized controlled trials reported on demographic and clinical characteristics. Issue 12 (5th October 2022) Authors: Pak, Joyce; Lund, Jennifer L.; Keil, Alexander; Westreich, Daniel; Stürmer, Til; Wohl, David; Farel, Claire; Drummond, M. Bradley; Webster‐Clark, Michael Journal: Pharmacoepidemiology and drug safety Issue: Volume 31:Issue 12(2022) Page Start: 1219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alternative analytic and matching approaches for the prevalent new‐user design: A simulation study. Issue 7 (13th May 2022) Authors: Webster‐Clark, Michael; Mavros, Panagiotis; Garry, Elizabeth M.; Stürmer, Til; Shmuel, Shahar; Young, Jessica; Girman, Cynthia Journal: Pharmacoepidemiology and drug safety Issue: Volume 31:Issue 7(2022) Page Start: 796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Assessing clinical trial effects on outcomes among pediatric and adolescent and young adult (AYA) patients with cancer. Issue 4 (29th October 2020) Authors: Shmuel, Shahar; Yang, Jeff Y.; Thai, Sydney; Webster‐Clark, Michael; Lund, Jennifer L. Journal: Cancer Issue: Volume 127:Issue 4(2021) Page Start: 648 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Introducing longitudinal cumulative dose to describe chemotherapy patterns over time: Case study of a colon cancer trial. Issue 2 (26th March 2021) Authors: Webster‐Clark, Michael; Keil, Alexander P.; Sanoff, Hanna K.; Stürmer, Til; Westreich, Daniel; Lund, Jennifer L. Journal: International journal of cancer Issue: Volume 149:Issue 2(2021) Page Start: 394 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Meta‐analysis with sample‐standardization in multi‐site studies. Issue 1 (2nd September 2022) Authors: Shu, Di; Webster‐Clark, Michael; Platt, Robert W.; Toh, Sengwee Journal: Pharmacoepidemiology and drug safety Issue: Volume 32:Issue 1(2023) Page Start: 56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Real‐world on‐treatment and initial treatment absolute risk differences for dabigatran vs warfarin in older US adults. Issue 8 (15th July 2020) Authors: Webster‐Clark, Michael; Stürmer, Til; Edwards, Jessie K.; Poole, Charles; Simpson, Ross J.; Lund, Jennifer L. Journal: Pharmacoepidemiology and drug safety Issue: Volume 29:Issue 8(2020) Page Start: 832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Translating claims‐based CHA2DS2‐VaSc and HAS‐BLED to ICD‐10‐CM: Impacts of mapping strategies. Issue 4 (17th February 2020) Authors: Webster‐Clark, Michael; Huang, Ting‐Ying; Hou, Laura; Toh, Sengwee Journal: Pharmacoepidemiology and drug safety Issue: Volume 29:Issue 4(2020) Page Start: 409 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Using propensity scores to estimate effects of treatment initiation decisions: State of the science. (29th December 2020) Authors: Webster‐Clark, Michael; Stürmer, Til; Wang, Tiansheng; Man, Kenneth; Marinac‐Dabic, Danica; Rothman, Kenneth J.; Ellis, Alan R.; Gokhale, Mugdha; Lunt, Mark; Girman, Cynthia; Glynn, Robert J. Journal: Statistics in medicine Issue: Volume 40:Number 7(2021) Page Start: 1718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Validation of a 5‐Year Mortality Prediction Model among U.S. Medicare Beneficiaries. Issue 12 (5th September 2020) Authors: Ross, Rachael K.; Kuo, Tzy‐Mey; Webster‐Clark, Michael; Lewis, Carmen L.; Kistler, Christine E.; Jonsson Funk, Michele; Lund, Jennifer L. Journal: Journal of the American Geriatrics Society Issue: Volume 68:Issue 12(2020) Page Start: 2898 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ways COVID‐19 may impact unrelated pharmacoepidemiologic research using routinely collected data. Issue 3 (16th December 2020) Authors: Webster‐Clark, Michael Journal: Pharmacoepidemiology and drug safety Issue: Volume 30:Issue 3(2021) Page Start: 400 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗